Mykola Zdioruk
Senior Scientist AstraZeneca
Seminars
Thursday 19th February 2026
Panel Discussion – Future Directions in GBM Models
12:30 pm
- Moving beyond traditional models to accurately replicate the TME and immune system of the human brain
- Outlining the technological innovations that are needed to make glioblastoma models truly predictive
- Standardizing models to ensure they are credible for regulatory submission and inform personalized medicine
Thursday 19th February 2026
Assessing the Current in Engineered Rodent Models of GBM to Align with Regulatory Requirements
11:30 am
- Evaluating the utility of genetically engineered mouse models, xenograft cell lines, and syngeneic models to determine their relevance and effectiveness in glioblastoma research
- Learning how to use these advanced models to accurately simulate the glioblastoma microenvironment and enhance the effectiveness of preclinical drug testing
- Identifying the most suitable modelling approaches for ensuring that preclinical findings are reliable and can be successfully translates into clinical applications
